COVID-19
Conditions
Keywords
COVID-19, Reproductive function, Sustained pregnancy rate
Brief summary
This multi-center, retrospective cohort study aimed to determine which factors are associated with ongoing pregnancy rates in infertile patients received ART treatments during the current outbreak of COVID-19 infection.Couples who underwent IVF-ET/ICSI-ET/FET due to infertility in the department of Reproductive Medicine from 2022-11-23 to 2023-01-07 were included. Patients who were infected with Coronavirus were observation groups; the infection status and clinical outcome were tracked. Patients who were not infected with Coronavirus were control groups.
Detailed description
In this multi-center, retrospective cohort study, we included patients who underwent IVF-ET/ICSI-ET/FET due to infertility in the department of Reproductive Medicine from 2022-11-23 to 2023-01-07. Patients who were infected with Coronavirus were observation groups; the infection status and clinical outcome were tracked. Patients who were not infected with Coronavirus were control groups. We compared different parameters between two groups. The primary outcome was ongoing pregnancy rate. Basic information about patients' menstruation, sexual desire, and sexual function were collected from Medical record system. Other information about patients' vaccination status, symptoms related to viral infection were collected by telephone follow ups. Susceptibility indicators to COVID-19 infection including fasting blood glucose, insulin, blood lipids, alpha-function, renin-angiotensinase, I-aldosterone were obtained . Reproductive function indices AMH, INHB, sex hormones, follicle retrieval rate, Gn days, total Gn, endometrial thickness, the incidence of OHSS, semen quality, oocyte maturation rate, fertilization rate, qualified embryo rate, blastocyst formation rate, and other laboratory indices of both men and women were also collected . Assisted pregnancy outcome: clinical pregnancy rate, embryo implantation rate, early abortion rate, ongoing pregnancy rate, and other clinical indicators were analyzed to determine whether there is deference in clinical outcomes between two groups.
Interventions
OTHERno intervention
no intervention
Sponsors
Jinling Hospital, China
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to 42 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosed with infertility * Patients with IVF-ET/ICSI-ET/FET from 2022/11/23 to 2023/01/07
Exclusion criteria
* Patients with contraindications to pregnancy or assisted reproductive technology
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Ongoing pregnancy rate | 3 months | If the fetal sac, fetal bud, and primitive fetal heartbeat are found by vaginal B-ultrasound examination 55-65 days after embryo transfer, the diagnosis of ongoing pregnancy will be made. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Outcome indicators of assisted pregnancy | 3 months | Embryo implantation rate, early abortion rate, ongoing pregnancy rate, incidence of OHSS |
| Clinical and laboratory indicators related to male and female reproductive function | 3 months | AMH, INB, sex hormone, follicle output rate, Gn days, total Gn, endometrial thickness on the embryo transfer day, semen quality; Oocyte maturation rate, fertilization rate, high-level embryo rate, blastocyst formation rate |
Other
| Measure | Time frame | Description |
|---|---|---|
| SAS Anxiety Scale | 3 months | SAS Anxiety Scale |
| Indicators of susceptibility to COVID-19 infection | 3 months | blood lipid, blood sugar, insulinand thyroid function |
| Coagulation index | 3 months | D-dimer |
| Oxidative stress index | 3 months | fingertip pulse oxygen saturation |
Countries
China
Contacts
Primary ContactBing Yao, PHD
Backup ContactLi Chen, PHD
Outcome results
None listed